Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.
about
Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus ErythematosusCellular targeting in autoimmunitySmall molecules in the treatment of systemic lupus erythematosusA Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint InflammationForce-dependent calcium signaling and its pathway of human neutrophils on P-selectin in flowTyrosine phosphorylation of 3BP2 regulates B cell receptor-mediated activation of NFATFostamatinib Disodium.The pathology of T cells in systemic lupus erythematosusSystems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.Pathogenesis of human systemic lupus erythematosus: recent advances.T-cell and B-cell signaling biomarkers and treatment targets in lupus.Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus.Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone miceCentral role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.T cells as therapeutic targets in SLE.Tyrosine kinases in inflammatory dermatologic disease.The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets.Spleen tyrosine kinase (Syk) regulates systemic lupus erythematosus (SLE) T cell signaling.Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines.Calcium signaling in systemic lupus erythematosus T cells: a treatment targetAbnormalities of T cell signaling in systemic lupus erythematosus.Induced expression of FcγRIIIa (CD16a) on CD4+ T cells triggers generation of IFN-γhigh subset.Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus.Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.T cells as a therapeutic target in SLE.Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations?Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression.T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.c-Jun and Ets2 proteins regulate expression of spleen tyrosine kinase in T cells.Molecular basis for T cell response induced by altered peptide ligand of type II collagen.Novel treatments for systemic lupus erythematosus.Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patientsPrevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid.Systemic lupus erythematosus: new molecular targets.A systemic lupus erythematosus gene expression array in disease diagnosis and classification: a preliminary report.Lipids rule: resetting lipid metabolism restores T cell function in systemic lupus erythematosus.Update on emerging drug therapies for systemic lupus erythematosus.Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments.PSGL-1: A New Player in the Immune Checkpoint Landscape.CREMα suppresses spleen tyrosine kinase expression in normal but not systemic lupus erythematosus T cells.
P2860
Q26773124-F18687EC-33CA-4C9C-98DB-D7DCC3B3625FQ26824580-690E84C9-5161-4705-B76E-86BE3D0CBAB9Q27010090-F06C5438-9C35-4746-BCC2-E3136FCDE37BQ28552367-4C1E5AEE-A745-4B26-AE53-0B97F647D37EQ28817487-D52B3A65-D30C-44BA-A179-7494BFCFB523Q30157087-D95D4A04-C963-4EF7-B7E1-A456FC6B5965Q33405080-D4713441-84AF-4A49-952C-AFBD405259B2Q33598213-8A39F82C-6AB1-4DF1-91FA-B9DB4B7BEB0CQ33608479-3D4434E0-8077-4362-9FB2-6109768CD957Q33664927-82DD2CBD-C0F9-42F6-A308-A7839CB0EFF8Q33718893-B6799046-B38C-4FE0-88F9-8394EAABB3FCQ33728674-FF7D0A05-9951-4671-8094-1EA4CC808525Q33987268-6E2E75B7-55F7-4F09-A79D-0C9A16B570F1Q34027578-42A11F17-A45C-4E29-8243-02064EDDA9F4Q34075552-95F00328-E733-4A1B-B2BF-9ACD81AE6E1FQ34166503-C206C654-1F40-4DD0-A75E-5602333AA08BQ34597949-B0DE4FBE-9A3A-4A6E-9E8D-39EE5D32B169Q34980925-26FE358A-3153-4854-81ED-65791ED2829BQ35065017-A1F0915B-CA4C-4B46-94E7-FB0E113175B5Q35082332-C464CFC9-7B56-4C7D-BE73-ABA6D2FC0D91Q35092855-5EB29C24-9392-4AEE-BB27-6479EFB8F997Q35104018-F4C422A8-E719-4B6D-BC4A-ABBF4945FB06Q35172134-47FB137F-071C-4DCE-8417-8B89DFB09532Q35210660-222EB7F1-90C4-4C26-905A-BF520757406CQ35214963-8858F100-55B8-4C5B-8D3C-6E43B92FF502Q35434205-6A04F55A-DD84-414A-B69C-70C64CC8BD10Q35809151-27CCDD45-F155-492E-BC5D-AD47E8E687E1Q35836112-C43F89A3-8D2D-40AE-A3F4-A5613A6BE7D6Q35874380-8FD41DCA-00EA-4F22-9C0D-6A13B261B0D9Q36003945-C7A7713B-FA1C-40A7-AA64-5F7013012F1FQ36059553-A5863432-13B4-461B-8F33-D1A949A36FE3Q36355671-02301741-F7E5-4BDE-9E3A-ECF44D6827B1Q36823420-2CE185E0-0F7C-48F3-B263-DD4627CDA0F7Q36969905-01D1878B-FD06-4ECF-84A3-AC4B36097D97Q37433446-8A466B36-ECAC-45B1-A34C-57383AE039E6Q37524335-3EF3E930-ADB7-414F-8735-6AC80B2A86E0Q37690745-88353EFD-38EB-48B4-81A5-09855E3A6084Q38192725-29B0445A-BB0D-4D32-AA8A-9FACB8DC7155Q39163377-2D217011-DB60-4AC7-AAB5-58FE52A163E5Q40134093-17398464-5AD5-4EC3-B14F-69166E13419D
P2860
Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Differential expression and mo ...... c lupus erythematosus T cells.
@en
type
label
Differential expression and mo ...... c lupus erythematosus T cells.
@en
prefLabel
Differential expression and mo ...... c lupus erythematosus T cells.
@en
P2093
P2860
P1476
Differential expression and mo ...... c lupus erythematosus T cells.
@en
P2093
Abigail Magilavy
Arthur Weinstein
Bhabadeb Chowdhury
Carolyn U Fisher
George C Tsokos
Hang Nguyen
Madhusoodana P Nambiar
Polly Pine
Rena Bahjat
Sandeep Krishnan
P2860
P304
P356
10.4049/JIMMUNOL.181.11.8145
P407
P577
2008-12-01T00:00:00Z